Delivery Order SPE2DB20D1109-SPE2DB25FP71D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,129.70 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's broader relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the...
- The Defense Logistics Agency awarded a $19,114.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, with an ultimate completion date of August 4, 2025. This non-set-aside award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, supporting federal medical procurement needs within...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,673.61 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The award represents a continuation of...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price delivery order, valued at $1,577.68, represents a competitively awarded contract with an ultimate completion date of July 22, 2025. The award was issued without a set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement requirements....
- The Defense Logistics Agency awarded a delivery order valued at $11,947.02 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials. The contract, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, is structured as a firm fixed price delivery order with no set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $131,234.68 on July 29, 2025, for the supply of Bridion 200mg/2mL (10 units). This competitively awarded, firm fixed price contract is not set-aside and will be completed by August 25, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain division and represents a child delivery order under AmerisourceBergen's larger prime Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials valued at $3,070.80, with an ultimate completion date of August 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,692.64 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract with performance to be conducted in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, valued at $13,599.02 under firm fixed price terms. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $27,945.02 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP71DDelivery Order
The Defense Logistics Agency awarded a $10,028.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 9, 2025, with completion expected by September 10, 2025. This non-set-aside contract represents a pharmaceutical supply delivery under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal military and veteran medical systems. This delivery order falls under AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract reflects the company's established capability to meet federal procurement requirements through competitive procurement processes, with the IDC serving as a flexible mechanism for DLA to fulfill ongoing pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 9/9/25 |